Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 2
1956 2
1957 1
1961 1
1963 2
1964 1
1966 2
1969 1
1970 1
1972 1
1973 1
1974 1
1975 3
1976 4
1977 1
1978 3
1980 5
1981 3
1982 1
1989 1
1990 2
1991 3
1992 4
1993 3
1994 1
1995 1
1996 3
1997 1
1998 1
1999 2
2000 1
2003 2
2004 1
2005 1
2006 1
2007 3
2008 1
2009 3
2010 1
2011 3
2012 3
2013 4
2014 1
2015 5
2016 2
2017 1
2018 1
2019 5
2020 9
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

108 results
Results by year
Filters applied: . Clear all
Page 1
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, Biello F, Barletta G, Rossi G, Tagliamento M, Maggioni C, Grossi F. Dal Bello MG, et al. Among authors: orengo am. J Transl Med. 2019 Mar 8;17(1):74. doi: 10.1186/s12967-019-1828-0. J Transl Med. 2019. PMID: 30849967 Free PMC article.
Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
Marini C, Cossu V, Bauckneht M, Lanfranchi F, Raffa S, Orengo AM, Ravera S, Bruno S, Sambuceti G. Marini C, et al. Among authors: orengo am. Biomolecules. 2021 Aug 18;11(8):1231. doi: 10.3390/biom11081231. Biomolecules. 2021. PMID: 34439897 Free PMC article. Review.
18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at?
Sambuceti G, Cossu V, Bauckneht M, Morbelli S, Orengo A, Carta S, Ravera S, Bruno S, Marini C. Sambuceti G, et al. Among authors: orengo a. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1278-1286. doi: 10.1007/s00259-021-05368-2. Eur J Nucl Med Mol Imaging. 2021. PMID: 33864142 No abstract available.
Immunotherapeutic applications of IL-15.
Croce M, Orengo AM, Azzarone B, Ferrini S. Croce M, et al. Among authors: orengo am. Immunotherapy. 2012 Sep;4(9):957-69. doi: 10.2217/imt.12.92. Immunotherapy. 2012. PMID: 23046239 Review.
Two high-rate pentose-phosphate pathways in cancer cells.
Cossu V, Bonanomi M, Bauckneht M, Ravera S, Righi N, Miceli A, Morbelli S, Orengo AM, Piccioli P, Bruno S, Gaglio D, Sambuceti G, Marini C. Cossu V, et al. Among authors: orengo am. Sci Rep. 2020 Dec 17;10(1):22111. doi: 10.1038/s41598-020-79185-2. Sci Rep. 2020. PMID: 33335166 Free PMC article.
A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome.
De Giovanni C, Nicoletti G, Palladini A, Croci S, Landuzzi L, Antognoli A, Murgo A, Astolfi A, Ferrini S, Fabbi M, Orengo AM, Amici A, Penichet ML, Aurisicchio L, Iezzi M, Musiani P, Nanni P, Lollini PL. De Giovanni C, et al. Among authors: orengo am. Hum Gene Ther. 2009 May;20(5):453-64. doi: 10.1089/hum.2008.172. Hum Gene Ther. 2009. PMID: 19215191
108 results